Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

SynCardia Retools To Accelerate Use Of CardioWest Artificial Heart

This article was originally published in The Gray Sheet

  • News

Executive Summary

SynCardia plans to distribute its total artificial heart to at least 10 additional U.S. transplant centers in 2006 now that it has reorganized to support sales and distribution

You may also be interested in...



CMS To Review Longstanding Non-Coverage Of Artificial Hearts

CMS is reviewing its longstanding non-coverage policy for artificial hearts in a response to a request from SynCardia Systems, 1the agency announced Aug. 1

CMS To Review Longstanding Non-Coverage Of Artificial Hearts

CMS is reviewing its longstanding non-coverage policy for artificial hearts in a response to a request from SynCardia Systems, 1the agency announced Aug. 1

Abiomed Artificial Heart HDE Voted Down By Cardio Panel In Wild Finish

Abiomed will give FDA additional anti-coagulation and quality-of-life data from a 14-patient trial supporting the firm's HDE application for the AbioCor total artificial heart, following a negative panel vote

Table

View full table

Tags:
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT023091

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By